More Positive Phase 2 Data for Zilebesiran in Hypertension More Positive Phase 2 Data for Zilebesiran in Hypertension

The investigational RNA interference therapeutic, zilebesiran, has shown positive top-line results in the KARDIA-2 phase 2 study in the treatment of hypertension.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology Source Type: news